Cancer Research

Gene Linked To Cancer Suppression May Actually Promote Its Spread

A gene believed to suppress the growth and spread of cancer has the opposite effect in some forms of colorectal cancer, researchers have found.  Sprouty2 is the gene and the new paper studied it in cancer cell models, mouse models and human biopsy samples ...

Article - News Staff - Jan 5 2016 - 10:01am

Childhood Leukemias: Different Forces Than Adults

For half a century, cancer researchers have struggled with a confusing paradox: If cancer is caused by the occurrence and accumulation of cancer-causing (oncogenic) mutations over time, young children should get less cancer since they have fewer mutations ...

Article - News Staff - Jan 12 2016 - 7:30am

New Data On Why Most Aggressive Brain Tumor Treatments Fail

Two small structural elements, called decorin and lumican, could be decisive in the development of a resistance to the drugs currently used for treating glioblastoma multiforme, such as temozolamide.   Glioblastoma multiforme is the most frequent and aggre ...

Article - News Staff - Feb 18 2016 - 7:30am

Skin Cells Turn Into Stem Cells That Are Cancer Cell Killers

Researchers have turned skin cells into cancer-hunting stem cells that destroy the brain tumors known as glioblastoma – a discovery that may offer a new and more effective treatment for the disease.  The survival rate beyond two years for a patient with a ...

Article - News Staff - Feb 26 2016 - 7:10am

Sunbather Paradox: Sun Worshippers Live Longer Than Those Who Avoid The Sun

Women who sunbathe are likely to live longer than those who avoid the sun, even though sunbathers are at an increased risk of developing skin cancer. This paradox baffles oncologists and has suggested that the war on sunshine has been unjustified. ...

Article - News Staff - Sep 29 2017 - 8:31pm

High Doses Of Common Chemo Drug Methotrexate Limit Relapses Of Childhood Leukemia

With a cure rate approaching 90 percent, acute lymphoblastic leukemia (ALL), the most common type of childhood cancer, is one of the big "success stories" of modern cancer treatment. Yet up to 20 percent of patients with a high risk of relapse a ...

Article - News Staff - Apr 25 2016 - 4:08pm

Testosterone Therapy Doesn't Raise Risk Of Aggressive Prostate Cancer In New Study

Men with low levels of the male sex hormone testosterone need not fear that testosterone replacement therapy will increase their risk of prostate cancer, according to an analysis of more than 250,000 medical records. In the study, researchers found that, ...

Article - News Staff - May 9 2016 - 7:02am

Up To 25% Of Lung Cancer Patients Can't Get Immunotherapy

Up to 25 percent of of lung cancer patients also have autoimmune disease, which may make them unsuitable for increasingly popular immunotherapy treatments. ...

Article - News Staff - Jun 5 2016 - 10:30am

Acute Myeloid Leukaemia Is At Least 11 Different Diseases

Acute Myeloid Leukaemia (AML) is not a single disorder, but at least 11 different diseases, and that genetic changes explain differences in survival among young AML patients, according to a new study on the genetics of AML in New England Journal of Medici ...

Article - News Staff - Jun 9 2016 - 6:01am

Isoform-based Biomarker Predictions Could Give Cancer Patients Better Survival Estimates

People with cancer are often told by their doctors approximately how long they have to live, and how well they will respond to treatments, but what if there were a way to improve the accuracy of those predictions? A new method could help, using data about ...

Article - News Staff - Jun 9 2016 - 7:17am